# US 2015/0105472 A1 · Antimicrobial composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0105472 A1
- Document ID: US20150105472A1
- Status: Published application
- Kind: A1
- Application number: 14/571,882
- Filed: 2014-12-16
- Published: 2015-04-16
- Earliest claimed: 2008-07-07
- Assignees: Ambria Dermatology AB
- Applicants: Ambria Dermatology AB
- Inventors: Jan FAERGEMANN
- Web page: https://patentgrep.com/patent/US20150105472A1

## CPC

- A61K 31/155: Amidines ([IMAGE cpc-sch-A61K-1029.gif]), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A01N 31/02: Acyclic compounds
- A01N 47/44: Guanidine; Derivatives thereof
- A61K 8/345: {containing more than one hydroxy group}
- A61K 8/43: Guanidines
- A61K 31/047: having two or more hydroxy groups, e.g. sorbitol
- A61P 17/00: Drugs for dermatological disorders
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/02: Local antiseptics
- A61P 31/04: Antibacterial agents
- A61Q 17/005: {Antimicrobial preparations}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The invention relates to an antimicrobial composition comprising chlorhexidine and pentane-1,5-diol. Such a composition may be used to combat microorganisms.

## Claims

### Claim 1

An antimicrobial composition comprising chlorhexidine and pentane-1,5-diol, wherein the composition comprises between 0.000001 and 5 wt % chlorhexidine and between 1 and 75 wt % pentane-1,5-diol.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein the composition comprises between 0.00001 and 5 wt % chlorhexidine and between 3 and 25 wt % pentane-1,5-diol.

### Claim 3 (depends on 2)

The composition according to claim 2, wherein the composition comprises between 0.001 and 2.5 wt % chlorhexidine and between 5 and 15 wt % pentane-1,5-diol.

### Claim 4 (depends on 1)

The composition according to claim 1, wherein said composition is a pharmaceutical composition.

### Claim 5 (depends on 4)

The composition according to claim 4, wherein said composition is for topical administration.

### Claim 6 (depends on 4)

The composition according to claim 4, wherein said composition comprises a carrier and a thickening agent.

### Claim 7 (depends on 1)

The composition according to claim 1 for use in therapy.

### Claim 8 (depends on 1)

Use of a composition according to claim 1 in non-therapeutic disinfection.

### Claim 9 (depends on 1)

The composition according to claim 1 for use in treating infections.

### Claim 10 (depends on 9)

The composition according to claim 9, wherein said infection is an infection affecting the skin.

### Claim 11

A method of treating an infection in a patient in need thereof comprising administering to the patient a pharmaceutical composition comprising chlorhexidine and pentane-1,5-diol, wherein the composition comprises between 0.000001 and 5 wt % chlorhexidine and between 1 and 75 wt % pentane-1,5-diol.

### Claim 12 (depends on 11)

The method of claim 11, wherein the patient is suffering from an infection of skin or mucous membrane.

### Claim 13 (depends on 12)

The method of claim 12, wherein the composition is administered topically to the skin or mucous membrane of the patient.

### Claim 14 (depends on 11)

The method of claim 11, wherein the composition is administered in an amount effective to inactivate a microorganism.

### Claim 15 (depends on 14)

The method of claim 14, wherein the microorganism is selected from one or more of the group consisting of Staphylococcus aureus, P. acnes, Streptococci, gram negative rodes, Candida albicans, Candida glabrata, Malassezia, the mould Aspergillus fumigatus and the dermatophytes Trichophyton rubrum, T. mentagrophytes, Epidermophyton floccusum, Microsporum canis, papilloma virus, herpes virus and pox virus.

### Claim 16 (depends on 15)

The method of claim 15, wherein the microorganism is selected from one or more of the group consisting of Staphylococcus aureus and P. acnes.

### Claim 17 (depends on 11)

The method of claim 11, wherein the composition comprises between 0.00001 and 5 wt % chlorhexidine and between 3 and 25 wt % pentane-1,5-diol.

### Claim 18 (depends on 11)

The method of claim 11, wherein the composition comprises between 0.001 and 2.5 wt % chlorhexidine and between 5 and 15 wt % pentane-1,5-diol.

### Claim 19 (depends on 11)

The method of claim 11, wherein the composition comprises a carrier and a thickening agent.

### Claim 20 (depends on 11)

The method of claim 11, wherein the composition further comprises one or more pharmaceutically acceptable adjuvants or excipients.
